BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 22142160)

  • 1. Inflammation-mediated changes in drug transporter expression/activity: implications for therapeutic drug response.
    Cressman AM; Petrovic V; Piquette-Miller M
    Expert Rev Clin Pharmacol; 2012 Jan; 5(1):69-89. PubMed ID: 22142160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of transporters by nuclear hormone receptors: implications during inflammation.
    Teng S; Piquette-Miller M
    Mol Pharm; 2008; 5(1):67-76. PubMed ID: 18072749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug trafficking: recent advances in therapeutics and disease.
    Sprowl JA; Sparreboom A
    Clin Pharmacol Ther; 2012 Nov; 92(5):531-4. PubMed ID: 23085872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of human hepatic drug transporter expression by pro-inflammatory cytokines.
    Fardel O; Le Vée M
    Expert Opin Drug Metab Toxicol; 2009 Dec; 5(12):1469-81. PubMed ID: 19785515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of inflammation on pharmacokinetics/pharmacodynamics: increasing recognition of its contribution to variability in response.
    Schmith VD; Foss JF
    Clin Pharmacol Ther; 2008 Jun; 83(6):809-11. PubMed ID: 18488052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetics of drug transporters in the enterohepatic circulation.
    Stieger B; Meier PJ
    Pharmacogenomics; 2011 May; 12(5):611-31. PubMed ID: 21619426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placental drug transporters and their role in fetal protection.
    Iqbal M; Audette MC; Petropoulos S; Gibb W; Matthews SG
    Placenta; 2012 Mar; 33(3):137-42. PubMed ID: 22265855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transporters and drug therapy: implications for drug disposition and disease.
    Ho RH; Kim RB
    Clin Pharmacol Ther; 2005 Sep; 78(3):260-77. PubMed ID: 16153397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The kidney--the body's playground for drugs: an overview of renal drug handling with selected clinical correlates.
    Perri D; Ito S; Rowsell V; Shear NH
    Can J Clin Pharmacol; 2003; 10(1):17-23. PubMed ID: 12687033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms of drug transporter regulation.
    Tirona RG
    Handb Exp Pharmacol; 2011; (201):373-402. PubMed ID: 21103976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammation: planning for a source of pharmacokinetic/pharmacodynamic variability in translational studies.
    Schmith VD; Foss JF
    Clin Pharmacol Ther; 2010 Apr; 87(4):488-91. PubMed ID: 20147898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of drug transporters by PDZ adaptor proteins and nuclear receptors.
    Kato Y; Watanabe C; Tsuji A
    Eur J Pharm Sci; 2006 Apr; 27(5):487-500. PubMed ID: 16376527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic implications of renal anionic drug transporters.
    Masereeuw R; Russel FG
    Pharmacol Ther; 2010 May; 126(2):200-16. PubMed ID: 20227439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic and/or non-genetic causes for inter-individual and inter-cellular variability in transporter protein expression: implications for understanding drug efficacy and toxicity.
    Koo SH; Lo YL; Yee JY; Lee EJ
    Expert Opin Drug Metab Toxicol; 2015; 11(12):1821-37. PubMed ID: 26489003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug transporters and renal drug disposition in the newborn.
    De Gregori S; De Gregori M; Ranzani GN; Borghesi A; Regazzi M; Stronati M
    J Matern Fetal Neonatal Med; 2009; 22 Suppl 3():31-7. PubMed ID: 19925361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scientific and regulatory perspectives on metabolizing enzyme-transporter interplay and its role in drug interactions: challenges in predicting drug interactions.
    Zhang L; Zhang Y; Huang SM
    Mol Pharm; 2009; 6(6):1766-74. PubMed ID: 19839641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Disease Pathologies on Transporter Expression and Function.
    Atilano-Roque A; Roda G; Fogueri U; Kiser JJ; Joy MS
    J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S205-21. PubMed ID: 27385176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic regulation of drug transporter expression in human tissues.
    Hirota T; Tanaka T; Takesue H; Ieiri I
    Expert Opin Drug Metab Toxicol; 2017 Jan; 13(1):19-30. PubMed ID: 27579666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation is a major regulator of drug metabolizing enzymes and transporters: Consequences for the personalization of drug treatment.
    Stanke-Labesque F; Gautier-Veyret E; Chhun S; Guilhaumou R;
    Pharmacol Ther; 2020 Nov; 215():107627. PubMed ID: 32659304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of transporters in drug interactions.
    Han HK
    Arch Pharm Res; 2011 Nov; 34(11):1865-77. PubMed ID: 22139686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.